Proactive research analyst John Savin speaks to Thomas Warner after publishing a new research note on Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF), a.
Voyageur Pharmaceuticals CEO Brent Willis joins Natalie Stoberman from the Proactive studios to discuss the successful completion of an environmental and.
Voyageur: Earthly profits from contrasting media Vertical integration to capture radiology contrast profits Voyageur Pharmaceuticals has a bold strategy to.
Proactive research analyst John Savin speaks to Thomas Warner after publishing a new research note on Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF), a.
Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) announced that it has successfully completed the environmental and geotechnical field work at its Frances.